Drug Profile
Amlodipine/indapamide/perindopril - Servier
Alternative Names: Indapamide/perindopril/amlodipine; Perindopril/indapamide/amlodipine; S06593; TriplixamLatest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator Servier
- Class Antihypertensives; Dihydropyridines; Indoles; Ischaemic heart disorder therapies; Small molecules; Sulfonamides
- Mechanism of Action ACE inhibitors; Calcium channel antagonists; Thiazide-like diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Essential hypertension
- No development reported Hypertension
Most Recent Events
- 28 Sep 2021 No development reported - Phase-III for Hypertension in India (PO)
- 30 Jun 2021 Launched for Essential hypertension in Czech Republic (PO)
- 07 Apr 2021 Launched for Essential hypertension in Ireland (PO)